W. Scott Douglas

Nov 4, 2024 | bmccancer.biomedcentral.com | W. Scott Douglas |La Trobe

The drugs used in this study were S63845 (Catalog #S8383, Selleck Chemicals, Houston, TX, USA), A-1331852 (Catalog #S7801, Selleck Chemicals), ABT-199 (MedChem Express, Monmouth Junction, NJ, USA), etoposide (Catalog #S1225, Selleck Chemicals; Jomar Life Research), regorafenib (Catalog #S1178, Selleck Chemicals), and Q-VD-OPh (Catalog #S7311, Selleck Chemicals).

Mar 14, 2023 | lexology.com | James Flood |Kate Beale |Byron Brown |Stacie Heller |W. Scott Douglas |Tim Shadyac

On March 9, 2023, President Biden released his fiscal year (FY) 2024 budget request outlining the administration’s priorities, including a nearly 10 percent increase in discretionary spending over the current enacted funding levels. The President’s budget requests a total of $6.9 trillion federal spending for FY 2024. Of this amount, $4.2 trillion would be in mandatory spending and $1.9 trillion would be in discretionary spending.